Buphthalmos: A Complete Guide

What is Buphthalmos?

Buphthalmos (pronounced “buh‑f‑thal‑‑mos”) is a medical term that describes an abnormal enlargement of the eyeball, most often noted in infants and young children. The word comes from the Greek bous (ox) and ophthalmos (eye) because the swollen eye can look “ox‑like.” The condition is usually a manifestation of severe, uncontrolled congenital glaucoma, but it may also arise from other ocular or systemic disorders that increase intra‑ocular pressure (IOP) or cause structural changes in the eye wall.

In a healthy eye, the cornea (the transparent front window) is smooth and measures about 11–12 mm in diameter. In buphthalmos, the cornea becomes markedly enlarged (often >13 mm) and may appear cloudy, hazy, or “bubbly.” Because the eye is still developing, the excess pressure stretches the sclera and cornea, leading to the characteristic enlargement.

Common Causes

The most frequent triggers for buphthalmos are conditions that raise intra‑ocular pressure in early life. Below are the eight‑to‑ten most common causes:

• Primary congenital glaucoma (PCG) – The leading cause; a developmental defect in the trabecular meshwork blocks aqueous outflow.
• Secondary congenital glaucoma – Results from other ocular anomalies such as anterior segment dysgenesis, microphthalmia, or Peters anomaly.
• Sturge‑Weber syndrome – A neuro‑cutaneous disorder with facial port‑wine stains and abnormal choroidal vessels that can increase IOP.
• Neurofibromatosis type 1 (NF1) – Plexiform neurofibromas may involve the orbit, compressing outflow pathways.
• Anterior segment dysgenesis (e.g., Axenfeld‑Rieger anomaly) – Malformation of the iris and drainage structures.
• Congenital cataract with secondary glaucoma – Lens abnormalities can obstruct the pupillary membrane.
• Traumatic injury in infancy – Penetrating or blunt trauma can scar the drainage angle.
• Infectious or inflammatory conditions – Congenital rubella, toxoplasmosis, or uveitis may lead to scarring and pressure elevation.
• Systemic syndromes with ocular involvement – Such as Marfan syndrome or homocystinuria, which affect connective tissue of the eye.
• Rare tumors – Like retinoblastoma or optic nerve glioma that mechanically increase intra‑ocular pressure.

Associated Symptoms

Buphthalmos rarely occurs in isolation. Children with an enlarged eye often show a constellation of symptoms that reflect high intra‑ocular pressure and corneal changes:

• Excessive tearing (epiphora) or watery discharge.
• Photophobia – sensitivity to light.
• Blepharospasm – frequent blinking or squinting.
• Corneal clouding or “hazy” appearance, sometimes described as a “milky” cornea.
• Enlarged ocular globe that is visibly larger than the fellow eye.
• Eye redness (conjunctival injection).
• Reduced visual acuity or delayed visual development.
• Horizontal or vertical nystagmus (involuntary eye movements).
• Headache or irritability in older infants who cannot verbalize discomfort.

When to See a Doctor

Early detection dramatically improves outcomes. Seek professional care promptly if you notice:

• A noticeable increase in the size of one or both eyes.
• Persistent tearing, eye redness, or a cloudy cornea.
• Any signs of visual impairment, such as the child not tracking objects.
• Frequent squinting, rubbing, or apparent eye pain.
• A family history of congenital glaucoma or related syndromes.

If any of these signs appear within the first few weeks to months of life, arrange an ophthalmology appointment as soon as possible. Early surgical intervention can preserve vision and prevent permanent damage.

Diagnosis

Evaluation of buphthalmos requires a combination of clinical examination and specialized testing:

• Comprehensive ocular exam – Includes measurement of corneal diameter with a caliper, assessment of corneal clarity, and inspection of the anterior chamber.
• Intra‑ocular pressure (IOP) measurement – Performed with a handheld tonometer (e.g., Perkins or iCare) suitable for infants.
• Gonioscopy – Direct visualization of the drainage angle to identify structural abnormalities.
• Ultrasound biomicroscopy (UBM) or anterior segment OCT – Provides high‑resolution images of the angle and cornea.
• Fundoscopic examination – Checks for optic nerve cupping, which indicates chronic pressure elevation.
• Genetic testing – May be recommended when syndromic causes (e.g., PCG‑related CYP1B1 mutations) are suspected.
• Systemic work‑up – If associated syndromes are suspected, a pediatrician may order brain MRI, skin examination, or blood tests.

The diagnosis is usually confirmed when an eye shows corneal diameter ≥13 mm (in infants) together with elevated IOP and one or more of the associated features listed above.

Treatment Options

Management aims to lower intra‑ocular pressure, protect the cornea, and preserve visual development. Treatment is multidisciplinary, involving pediatric ophthalmologists, glaucoma specialists, and sometimes genetic counselors.

Medical (Pharmacologic) Therapy

• Topical beta‑blockers (e.g., timolol) – Reduce aqueous production.
• Prostaglandin analogs (e.g., latanoprost) – Increase outflow through the uveoscleral pathway; used cautiously in infants.
• Carbonic anhydrase inhibitors (e.g., dorzolamide, oral acetazolamide) – Decrease fluid production.
• Alpha‑agonists (e.g., brimonidine) – Dual action of decreased production and increased outflow; not first‑line in very young children due to systemic side effects.

Medical therapy alone is rarely sufficient for primary congenital glaucoma; it is usually a bridge to surgery or used post‑operatively to maintain target IOP.

Surgical Interventions

Because the pediatric angle is often malformed, surgery is the definitive treatment for most cases.

• Goniotomy – An incision of the trabecular meshwork performed under a microscope; first‑line for PCG when the cornea is clear enough for visualization.
• Trabeculotomy – External approach that opens the Schlemm’s canal; useful when corneal opacity precludes goniotomy.
• Combined trabeculotomy–goniotomy – Used in severe cases to maximize outflow.
• Aqueous shunt implantation (e.g., Ahmed, Baerveldt) – Reserved for refractory cases where angle surgery fails.
• Cyclophotocoagulation – Laser treatment ablates ciliary body tissue to reduce fluid production; considered in eyes with very poor visual potential.

Rehabilitation & Vision Support

• Prescription glasses or contact lenses if refractive error develops.
• Occlusion therapy (patching) for amblyopia if one eye’s vision lags behind.
• Low‑vision services and early childhood visual stimulation programs.

Home & Supportive Care

• Administer eye drops as directed; using a punctual plug can help prevent systemic absorption.
• Maintain regular follow‑up appointments (often every 1–3 months in the first year).
• Protect the eyes from trauma – use protective eyewear during play.
• Ensure a balanced diet rich in omega‑3 fatty acids and antioxidants, which support overall ocular health.

Prevention Tips

While many cases of buphthalmos stem from genetic or developmental anomalies that cannot be prevented, certain steps can reduce the risk of secondary causes or facilitate earlier detection:

• Early newborn eye screening – Pediatricians should perform the red‑reflex test at birth and during well‑child visits; abnormal findings warrant urgent referral.
• Family planning counseling – Parents with a known history of congenital glaucoma should consider genetic counseling before conceiving.
• Control maternal infections – Rubella vaccination before pregnancy and avoidance of toxoplasma exposure reduce intra‑uterine infection risk.
• Prompt treatment of ocular infections or inflammation in infants to prevent scarring of the drainage angle.
• Safe handling of infants – Avoid blunt facial trauma; use car seats and play areas that minimize accidental blows to the eye.
• Regular pediatric eye exams – Especially for children with systemic syndromes known to affect the eye (e.g., Sturge‑Weber, NF‑1).

Emergency Warning Signs

References:
1. Mayo Clinic. “Congenital glaucoma.” https://www.mayoclinic.org.
2. American Academy of Ophthalmology. “Pediatric Glaucoma.” https://www.aao.org.
3. National Eye Institute (NEI). “Glaucoma in Children.” https://www.nei.nih.gov.
4. World Health Organization. “Global action plan for the prevention of avoidable blindness.” 2020.
5. St. John, R. et al. “Outcomes of primary trabeculotomy in congenital glaucoma.” Ophthalmology, 2022;129(4):450‑459.
6. Cleveland Clinic. “Buphthalmos (enlarged eye).” https://my.clevelandclinic.org.